Tahara_2016_Curr.Vasc.Pharmacol_14_552

Reference

Title : Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients - Tahara_2016_Curr.Vasc.Pharmacol_14_552
Author(s) : Tahara N , Yamagishi SI , Bekki M , Kodama N , Nakamura T , Sugiyama Y , Oshige T , Kumashiro Y , Honda A , Tahara A , Igata S , Fukumoto Y
Ref : Curr Vasc Pharmacol , 14 :552 , 2016
Abstract : Tahara_2016_Curr.Vasc.Pharmacol_14_552
ESTHER : Tahara_2016_Curr.Vasc.Pharmacol_14_552
PubMedSearch : Tahara_2016_Curr.Vasc.Pharmacol_14_552
PubMedID: 27357182

Related information

Citations formats

Tahara N, Yamagishi SI, Bekki M, Kodama N, Nakamura T, Sugiyama Y, Oshige T, Kumashiro Y, Honda A, Tahara A, Igata S, Fukumoto Y (2016)
Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients
Curr Vasc Pharmacol 14 :552

Tahara N, Yamagishi SI, Bekki M, Kodama N, Nakamura T, Sugiyama Y, Oshige T, Kumashiro Y, Honda A, Tahara A, Igata S, Fukumoto Y (2016)
Curr Vasc Pharmacol 14 :552